Piramal Pharma Solutions launches ADCelerate
ADCelerate is a new, branded solution for antibody-drug conjugate drug development
Drug Discovery & Development | 13/10/2022 | By Sudeep Soparkar | 486
IIL to invest Rs700 Cr in Hyd for new animal vaccine facility
The facility is intended to be a state-of-art fully integrated biosafety level 3 (BSL-3) for Drug substance (DS) production and respective fill-finish
Drug Discovery & Development | 11/10/2022 | By Sudeep Soparkar | 810
Eisai completes construction of new injection/research building at Kawashima Industrial Park, Japan
Eisai Medicine Innovation Technology Solutions will be Eisai's global base for formulation and modality research
Drug Discovery & Development | 06/10/2022 | By Sudeep Soparkar | 876
WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility
New facility expands integrated drug product R&D and manufacturing services to global customers
Drug Discovery & Development | 27/09/2022 | By Sudeep Soparkar | 649
Rely+On Virkon from LANXESS effective against monkeypox virus
Effectiveness of Rely+On Virkon scientifically proven
Disinfection a key to help prevent transmission
Hygiene best practices essential
Drug Discovery & Development | 26/09/2022 | By Sudeep Soparkar | 781
Merck India inaugurates R&D Excellence Centre in Bengaluru
Since 2020 the Excellence centre has onboarded around 300 employees and will continue its expansion over the next two years
Drug Discovery & Development | 02/09/2022 | By Sudeep Soparkar | 1095
CELLINK to establish CoE in India with IISc
The Centre of Excellence (CoE) will be focused on advancing research across heart, bone, cartilage and cancer research through the use of 3D bioprinting.
Drug Discovery & Development | 26/08/2022 | By Sudeep Soparkar | 466
AD Ports Group, Hayat Biotech partner to upgrade logistics solutions
The facilities will produce several vital biopharmaceutical products, including the Hayat-Vax vaccine, the first indigenously produced COVID-19 vaccine in the UAE
Drug Discovery & Development | 15/07/2022 | By Sudeep Soparkar | 797
Glenmark launches Type 2 diabetes drugs in India
The company has introduced 8 different combinations of sitagliptin-based drugs under the brand name SITAZIT<br />
Drug Discovery & Development | 07/07/2022 | By Sudeep Soparkar | 845
Aurigene Discovery Technologies inks partnership with EQRx
The parties would share both fundings for the discovery and development of the programmes
Drug Discovery & Development | 05/07/2022 | By Sudeep Soparkar | 953
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy